Diagnostic and prognostic value of low QRS voltages in cardiomyopathies: old but gold

Eur J Prev Cardiol. 2022 May 27;29(8):1177-1187. doi: 10.1093/eurjpc/zwaa027.

Abstract

The interpretation of 12-lead resting electrocardiogram (ECG) in patients with a definitive diagnosis or with the suspicion of a cardiomyopathy represents a cornerstone for the diagnostic work up and management of patients. Although low electrocardiographic QRS voltages (LQRSV) detected by 12-lead resting ECG have historically been acknowledged by physicians, in view of recent evidence on the demonstration of myocardial scar by cardiac magnetic resonance and its relevance as a cause of sudden cardiac death even in young individuals, a new interest has been raised about the utility of LQRSV in the clinical practice. Beyond their diagnostic value, LQRSV have also demonstrated a prognostic role in different cardiomyopathies. The present review summarizes the diagnostic and prognostic value of LQRSV in cardiomyopathies, reporting the new evidence, primarily based on advanced imaging studies, supporting the clinical utility of this parameter.

Keywords: ECG; amyloidosis; arrhythmogenic cardiomyopathy; hypertrophic cardiomyopathy; non-ischemic LV scar; sudden cardiac death.

Publication types

  • Review

MeSH terms

  • Arrhythmias, Cardiac / diagnosis
  • Cardiomyopathies* / diagnosis
  • Death, Sudden, Cardiac / etiology
  • Death, Sudden, Cardiac / prevention & control
  • Electrocardiography / methods
  • Humans
  • Prognosis